What is LBR Regulatory?
LBR Regulatory operates as a full-service Contract Research Organisation (CRO) providing end-to-end support for the pharmaceutical and medical device sectors. The firm distinguishes itself through a specialized focus on regulatory strategic planning, clinical trial execution, and rigorous quality assurance. By catering specifically to the unique requirements of start-ups and mid-sized enterprises, LBR Regulatory bridges the gap between early-stage innovation and commercial viability. Their operational model is built upon deep expertise in global regulatory frameworks and Good Clinical Practice (GCP) standards, allowing them to manage complex clinical studies across diverse therapeutic areas with high precision and scalability.
How much funding has LBR Regulatory raised?
LBR Regulatory has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in LBR Regulatory
PPP
Public-Private Partnership
What's next for LBR Regulatory?
With this late-stage capital injection, LBR Regulatory is poised to scale its infrastructure to meet the increasing demand for outsourced clinical development services. The strategic roadmap likely involves expanding their regulatory and medical writing capabilities to support more complex global submissions. Furthermore, the firm is expected to enhance its technological footprint in clinical trial management, ensuring that its clients can navigate the increasingly stringent regulatory environment with greater efficiency. As the company matures, this investment will serve as a catalyst for broader market penetration and the potential development of proprietary tools to streamline the drug approval process.
See full LBR Regulatory company page
